Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2014-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD004868.pub4PMID 24760628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Published by John Wiley & Sons Ltd

  2015cited by this paper
• Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2014cited by this paper
• A randomized, masked study of weekly erythropoietin dosing in preterm infants.

  2012cited by this paper
• Improving the reporting of randomised trials: the CONSORT Statement and beyond

  2012cited by this paper
• Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2012cited by this paper
• Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2012cited by this paper
• Very low birth weight infants qualifying for a ‘late’ erythrocyte transfusion: Does giving darbepoetin along with the transfusion counteract the transfusion's erythropoietic suppression?

  2011cited by this paper
• Erythropoietin for term and late preterm infants with hypoxic ischemic encephalopathy

  2010cited by this paper
• Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery.

  2009cited by this paper
• Enteral erythropoietin increases plasma erythropoietin level in preterm infants: a randomized controlled trial.

  2008cited by this paper
• Characterization and Differentiation of Iron Status in Anemic Very Low Birth Weight Infants Using a Diagnostic Nomogram

  2008cited by this paper
• The Effect of Human Recombinant Erythropoietin on Prevention of Anemia of Prematurity

  2007cited by this paper
• Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2007cited by this paper
• Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2006cited by this paper
• Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines.

  2006cited by this paper
• Erythrocyte iron incorporation but not absorption is increased by intravenous iron administration in erythropoietin-treated premature infants.

  2006cited by this paper
• Blood transfusion: a practical guide.

  2006cited by this paper
• EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY

  2005cited by this paper
• Effect of Short-Term Erythropoietin Therapy in Anemic Premature Infants

  2005cited by this paper
• Single-Dose Darbepoetin Administration to Anemic Preterm Neonates

  2005cited by this paper
• Effect of Beginning Recombinant Erythropoietin Treatment Within the First Week of Life, Among Very-Low-Birth-Weight Neonates, on “Early” and “Late” Erythrocyte Transfusions: A Meta-Analysis

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates.

  2003cited by this paper
• Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity

  2003cited by this paper
• Erythropoietin in the central nervous system, and its use to prevent hypoxic‐ischemic brain damage

  2002cited by this paper
• Effect of Recombinant Erythropoietin on “Late” Transfusions in the Neonatal Intensive Care Unit: A Meta-Analysis

  2002cited by this paper
• Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out.

  2002cited by this paper
• Iron status and the treatment of the anemia of prematurity.

  2002cited by this paper
• Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.

  2002cited by this paper
• Efficacy of erythropoietin in premature infants.

  2002cited by this paper
• Does early erythropoietin therapy decrease transfusions in anemia of prematurity ?

  2002cited by this paper
• Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants.

  2001cited by this paper
• [The effect of recombinant human erythropoietin on the treatment of anemia of prematurity]

  2001cited by this paper
• Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.

  2001cited by this paper
• The Biology of Erythropoietin in the Central Nervous System and Its Neurotrophic and Neuroprotective Potential

  2001cited by this paper
• Meta‐analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity

  2001cited by this paper
• Erythropoietin Therapy for Premature Infants: Cost without Benefit?

  2000cited by this paper
• Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?

  2000cited by this paper
• The use of erythropoietin in neonates.

  2000cited by this paper
• Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants

  1999cited by this paper
• Neurodevelopmental Outcome of Prematurely Born Children Treated With Recombinant Human Erythropoietin in Infancy

  1999cited by this paper
• Recombinant human erythropoietin in anemia of prematurity.

  1999cited by this paper
• Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.

  1998cited by this paper
• Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life.

  1998cited by this paper
• Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.

  1998cited by this paper
• Transfusion practices in infants receiving assisted ventilation.

  1998cited by this paper
• Blood transfusion

  1997cited by this paper
• [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].

  1997cited by this paper
• [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity]

  1997cited by this paper
• Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease

  1997cited by this paper
• Erythrocyte Incorporation and Absorption of 58Fe in Premature Infants Treated with Erythropoietin

  1997cited by this paper
• A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.

  1996cited by this paper
• Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity

  1996cited by this paper
• Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective?

  1996cited by this paper
• Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism

  1996cited by this paper
• CHANGING PATTERNS OF RED BLOOD CELL TRANSFUSION IN VERY LOW BIRTHWEIGHT INFANTS. † 1500

  1996cited by this paper
• Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity.

  1996cited by this paper
• Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake

  1996cited by this paper
• Effects of Recombinant Human Erythropoietin in Infants with Very Low Birth Weights

  1996cited by this paper
• Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions.

  1996cited by this paper
• Effect of recombinant human erythropoietin on the switchover from fetal to adult hemoglobin synthesis in preterm infants.

  1995cited by this paper
• Enhancement of erythropoiesis by erythropoietin, bovine protein and energy fortified mother's milk during anaemia of prematurity

  1995cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Effects of Recombinant Human Erythropoietin on Fetal and Adult Hemoglobin in Preterm Infants

  1995cited by this paper
• Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.

  1995cited by this paper
• Recombinant Human Erythropoietin in the Treatment of Anemia of Prematurity

  1995cited by this paper
• Recombinant Human Erythropoietin (r-HuEPO) Increases Total Bilirubin Production in Premature Infants

  1995cited by this paper
• Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.

  1994cited by this paper
• Erythropoiesis during Rapid Growth

  1994cited by this paper
• Double blind trial of recombinant human erythropoietin in preterm infants.

  1993cited by this paper
• Early treatment of premature infants with recombinant human erythropoietin

  1993cited by this paper
• Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.

  1993cited by this paper
• Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.

  1992cited by this paper
• Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

  1991cited by this paper
• Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.

  1991cited by this paper
• Blood sampling in very low birth weight infants receiving different levels of intensive care

  1988cited by this paper
• Circulating erythroid progenitors in the anemia of prematurity.

  1987cited by this paper
• Current Issues in Neonatal Transfusions

  1986cited by this paper
• Anemia of prematurity. Current concepts in the issue of when to transfuse.

  1986cited by this paper
• Postnatal changes in erythropoietin levels in untransfused premature infants.

  1983cited by this paper
• Erythropoiesis, erythropoietin, and iron

  1982cited by this paper
• Erythropoiesis, erythropoietin, and iron.

  1982cited by this paper
• Studies on the liver to kidney switch of erythropoietin production.

  1981cited by this paper
• Anemia of prematurity.

  1981cited by this paper
• Physiological anaemia of infancy and the anaemia of prematurity.

  1978cited by this paper

• Development of an electrochemiluminescence assay to measure serum darbepoetin concentration in extremely preterm infants.

  2025cites this paper
• Decreasing Blood Transfusions in Premature Infants Through Quality Improvement.

  2024cites this paper
• Effect of Early Erythropoietin on Retinopathy of Prematurity: A Stratified Meta-Analysis

  2023cites this paper
• Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.

  2023cites this paper
• Quantification of quercetin from red onion (Allium cepa L.) powder via high‐performance liquid chromatography‐ultraviolet (HPLC‐UV) and its effect on hyperuricemia in male healthy Wistar albino rats

  2023cites this paper
• Erythropoietin for preventing bronchopulmonary dysplasia in preterm infants: A systematic review and meta‐analysis

  2022cites this paper
• Identification and management of fetal anemia due to hemolytic disease

  2022cites this paper
• Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again

  2021cites this paper
• 4th Congress of Joint European Neonatal Societies: Epidemiology

  2021cites this paper
• Anemia of prematurity: how low is too low?

  2021cites this paper
• Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial.

  2020cites this paper
• The role of recombinant Human erythropoietin in neonatal anemia.

  2020cites this paper
• High-Dose Erythropoietin in Extremely Low Gestational Age Neonates Does Not Alter Risk of Retinopathy of Prematurity

  2020cites this paper
• Transfusion support: Considerations in pediatric populations.

  2020cites this paper
• Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

  2020cites this paper
• Neonatal red blood cell transfusion

  2020cites this paper
• Updates in Neonatal Anemia and Thrombocytopenia: Causes, Risk Factors, and Management

  2020cites this paper
• High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.

  2020cites this paper
• Are single-donor red blood cell transfusions still relevant for preterm infants?

  2020cites this paper
• Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

  2019cites this paper
• Updates in Neonatal Hematology: Causes, Risk Factors, and Management of Anemia and Thrombocytopenia.

  2019cites this paper
• Epidemiology of Necrotizing Enterocolitis: New Considerations Regarding the Influence of Red Blood Cell Transfusions and Anemia.

  2019cites this paper
• Cord blood stem cells to reduce preterm brain injury

  2019cites this paper
• Growth and Development

  2019cites this paper
• Epidemiology of NEC: New Considerations Regarding the Influence of Red Blood Cell Transfusions and Anemia

  2019cites this paper
• Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

  2019cites this paper
• Update on Erythropoiesis-Stimulating Agents Administered to Neonates for Neuroprotection.

  2019cites this paper
• Эффективность применения различных схем терапии рекомбинантным человеческим эритропоэтином у детей с очень низкой и экстремально низкой массой тела

  2019cites this paper
• Erythropoietin treatment is associated with a reduction in moderate to severe bronchopulmonary dysplasia in preterm infants. A regional retrospective study.

  2019cites this paper
• The Use of Erythropoietin for Anemia of Prematurity in North of Jordan, Outcome and Impact on Blood Transfusion

  2018cites this paper
• Neonatal RBC transfusions: Do benefits outweigh risks?

  2018cites this paper
• Retinopathy of prematurity: a review of risk factors and their clinical significance.

  2018cites this paper
• Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity

  2018cites this paper
• Blood transfusion for anaemia of prematurity: Current practice in Australia and New Zealand

  2018cites this paper
• The progress of prophylactic treatment in retinopathy of prematurity.

  2018cites this paper
• Clinical Outcomes Related to the Gastrointestinal Trophic Effects of Erythropoietin in Preterm Neonates: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Red Blood Cell Transfusion in Preterm Infants: Current Evidence and Controversies

  2018cites this paper
• The Erythropoietin Promoter Variant rs1617640 Is Not Associated with Severe Retinopathy of Prematurity, Independent of Treatment with Erythropoietin

  2018cites this paper
• Neonatal Erythrocyte Disorders

  2018cites this paper
• Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants.

  2017cites this paper
• National Guideline Clearinghouse Guideline summary NGC: 2016 Patient blood management guidelines Module 6. Neonatal and paediatrics

  2017cites this paper
• Therapeutic Strategies for Leukodystrophic Disorders Resulting from Perinatal Asphyxia: Focus on Myelinating Oligodendrocytes

  2017cites this paper
• [Blood transfusion to pre-term neonates: What is new in the French guidelines since 2002?]

  2017cites this paper
• A Comparison of Once- and Thrice-Weekly Erythropoietin Dosing for the Treatment of Anaemia of Prematurity.

  2017cites this paper
• Transfusion de culot globulaire chez le nouveau-né grand prématuré : ce qui a changé dans les recommandations françaises depuis 2002

  2017cites this paper
• 50 – Les anémies du prématuré : physiopathologies et évidences pour la transfusion

  2017cites this paper
• Gut and cerebral perfusion and oxygenation in preterm infants receiving blood transfusion

  2017cites this paper
• Early predictors of neonatal intraventricular hemorrhage

  2017cites this paper
• Exogenous erythropoietin aggravates retinal neovascularizationin a murine model of proliferative retinopathy

  2017influential citation
• Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

  2017cites this paper
• 116 – Developmental Erythropoiesis

  2017cites this paper
• 19 – Hypoxic-Ischemic Brain Injury in the Term Newborn

  2017cites this paper
• Disminución de transfusiones en prematuros con anemia tratados con Eritropoyetina

  2016cites this paper
• Research Opportunities to Improve Neonatal Red Blood Cell Transfusion.

  2016cites this paper
• Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity

  2016cites this paper
• Guidelines on transfusion for fetuses, neonates and older children

  2016cites this paper
• Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis

  2016cites this paper
• Neonatal Transfusion Practice: When do Neonates Need Red Blood Cells or Platelets?

  2016cites this paper
• Biochemical Markers of In Vivo Hepatotoxicity

  2016cites this paper
• Anemia and transfusion in the neonate.

  2016cites this paper
• Treatment with Erythropoietin in Neonatology

  2016cites this paper
• In Reply.

  2016cites this paper
• Unique aspects of red blood cell transfusion in pediatric patients

  2016cites this paper
• Non‐Pulmonary Management of Newborns with Respiratory Distress

  2016cites this paper
• Karakteristik Bayi Prematur yang Mengalami Anemia dan Tranfusi PRC Sebelum Usia Kronologis 4 Minggu

  2016influential citation
• Erythropoese stimulierende Pharmaka (ESP)

  2016cites this paper
• Association between anemia and bronchopulmonary dysplasia in preterm infants

  2016cites this paper
• [Recombinant human erythropoietin in neonates: guidelines for clinical practice from the French Society of Neonatology].

  2015cites this paper
• Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair)

  2015cites this paper
• L’érythropoïétine humaine recombinante chez le nouveau-né : recommandations pour la pratique clinique de la Société française de néonatologie

  2015cites this paper
• Neonatal hypoxic ischaemic encephalopathy: current and future treatment options

  2015cites this paper
• Anaemia in the Premature Infant and Red Blood Cell Transfusion: New Approaches to an Age-Old Problem

  2015cites this paper
• Developing Indigenous Therapeutic Calcium Supplementation for Treating Nutritional Rickets.

  2015cites this paper
• Minimizing blood loss and the need for transfusions in very premature infants.

  2015cites this paper
• Limiter les pertes de sang et le recours aux transfusions chez les grands prématurés

  2015cites this paper
• Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.

  2015cites this paper
• Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.

  2015cites this paper
• Cognitive Outcomes of Preterm Infants Randomized to Darbepoetin, Erythropoietin, or Placebo

  2014cites this paper
• The potential of erythropoietin to treat asphyxia in newborns

  2014cites this paper
• Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates?

  2014cites this paper
• Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2014cites this paper
• Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns.

  2014cites this paper
• Management and prevention of neonatal anemia: current evidence and guidelines

  2014cites this paper
• Use of erythropoietin is associated with threshold retinopathy of prematurity (ROP) in preterm ELBW neonates: a retrospective, cohort study from two large tertiary NICUs in Italy.

  2014cites this paper
• Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates

  2014cites this paper
• Erythropoietin and retinopathy of prematurity: a meta-analysis

  2014cites this paper
• Evidence-Based Advances in Transfusion Practice in Neonatal Intensive Care Units

  2014cites this paper
• Red blood cell transfusion in preterm neonates: current perspectives

  2014cites this paper
• Clinical characteristics of monochorionic twins with large hemoglobin level discordance at birth

  2014cites this paper
• Could Cord Blood Cell Therapy Reduce Preterm Brain Injury?

  2014cites this paper
• How we decide when a neonate needs a transfusion

  2013cites this paper
• Comparison of Oral and Injection Erythropoietin on Level of Hemoglobin Concentration in Premature Neonates: A Randomized Controlled Trials;

  2013cites this paper
• Why study erythropoietin in preterm infants?

  2013cites this paper
• The AKT/mTOR pathway mediates neuronal protective effects of erythropoietin in sepsis

  2013cites this paper
• Stimulating erythropoiesis in neonates

  2013cites this paper
• Valores normales de la enzima β-Glucosidasa Citosolica en lactantes menores de dos meses.Utilidad como biomarcador en tiempo real de diagnóstico de enterocolitis necrotizante del lactante: valores predictivos, sensibilidad y especificidad

  2013cites this paper
• Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants

  2013cites this paper
• Eficacia y seguridad de la eritropoyetina en la anemia de la prematuridad

  2013cites this paper
• A Randomized, Masked, Placebo-Controlled Study of Darbepoetin Alfa in Preterm Infants

  2013cites this paper
• Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia.

  2013cites this paper